A Safety Clinical Trial of Different Doses of MEDI-507 in the Prevention of Acute Renal Allograft Rejection

Status:
Completed

Trial end date:
1998-01-01

Target enrollment:

Participant gender:

To evaluate the clinical safety of different doses of MEDI-507 through day 33.

Phase 1

MedImmune LLC